Skip to main content

Want a detailed portfolio tracker?

Structure Therapeutics (GPCR) P/E (2023 - 2026)

Structure Therapeutics (GPCR) P/E from Mar 31, 2023 to Jul 21, 2026. The TTM Structure Therapeutics (GPCR) P/E is -17.90. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Structure Therapeutics (GPCR)

YearP/EChange
2026-17.90-35.61%
2025-27.80+130.00%
2024-12.09-49.55%
2023-23.96N/A

Comparison Structure Therapeutics (GPCR) P/E with competitors

Structure Therapeutics (GPCR) P/E is -17.90.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.42%
FGENFibroGen Inc0.24-101.34%
CHRSCoherus Biosciences Inc0.85-104.74%
FBIOFortress Biotech Inc0.95-105.30%
ORMPOramed Pharmaceuticals Inc1.50-108.40%
AGENAgenus Inc3.01-116.81%
INVAInnoviva Inc3.15-117.62%
VXRTVaxart Inc3.55-119.83%
CRMDCorMedix Inc3.63-120.27%
CVACCureVac N.V.4.45-124.84%
GLPGGalapagos NV4.86-127.15%
SRPTSarepta Therapeutics Inc4.88-127.27%
ABEOAbeona Therapeutics Inc5.39-130.10%
ABUSArbutus Biopharma Corp5.60-131.26%
ZVRAZevra Therapeutics Inc5.89-132.89%
SPROSpero Therapeutics Inc6.23-134.80%
CGENCompugen Ltd6.31-135.27%
RIGLRigel Pharmaceuticals6.87-138.39%
SLXNSilexion Therapeutics Corp7.30-140.76%
OMEROmeros Corporation9.26-151.73%
AUPHAurinia Pharmaceuticals Inc9.58-153.55%
PLXProtalix BioTherapeutics Inc10.89-160.84%
ACADAcadia Pharmaceuticals Inc11.73-165.52%
TBPHTheravance Biopharma Inc12.26-168.51%
ADMAAdma Biologics Inc12.42-169.38%
HRMYHarmony Biosciences Holdings Inc13.82-177.21%
SABSSAB Biotherapeutics Inc14.14-178.97%
NAGENiagen Bioscience Inc14.82-182.78%
INCYIncyte Corp15.82-188.40%
REGNRegeneron Pharmaceuticals Inc15.86-188.59%
PBYIPuma Biotechnology Inc17.32-196.74%
CPRXCatalyst Pharmaceuticals Inc17.44-197.43%
EXELExelixis Inc17.54-197.98%
TGTXTG Therapeutics Inc18.97-205.96%
MDXGMimedx Group Inc20.55-214.82%
XOMAXOMA Royalty Corp22.87-227.80%
ARGXArgen X SE24.30-235.75%
CTMXCytomX Therapeutics Inc24.82-238.67%
XOMAOXOMA Royalty Corp25.34-241.60%
HALOHalozyme Therapeutics Inc25.62-243.16%
XOMAPXOMA Royalty Corp25.67-243.42%
VRTXVertex Pharmaceuticals Inc27.99-256.40%
RPRXRoyalty Pharma plc - Class A28.69-260.27%
SLNOSoleno Therapeutics Inc29.02-262.10%
ASNDAscendis Pharma A/S30.09-268.08%
LGNDLigand Pharmaceuticals Inc - Class B37.91-311.81%
APLSApellis Pharmaceuticals Inc39.02-318.01%
BMRNBiomarin Pharmaceutical Inc42.21-335.83%
KRYSKrystal Biotech Inc45.34-353.33%
ONCBeiGene Ltd69.54-488.51%
PHARPharming Group N.V.75.03-519.16%
TECHBio-Techne Corp101.96-669.63%
VCELVericel Corp109.92-714.12%
ALNYAlnylam Pharmaceuticals Inc117.96-759.06%
GMABGenmab140.29-883.79%
TLXTelix Pharmaceuticals Ltd162.15-1005.93%
CORTCorcept Therapeutics Inc212.86-1289.21%